Imidazole derivatives having 5-ht3 receptor antagonist activity

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/208, 260/305

C07D 233/64 (2006.01) A61K 31/415 (2006.01) C07D 403/06 (2006.01)

Patent

CA 1310960

- 1 - Abstract Compounds of formula (I) and pharmaceutically acceptable salts thereof: Image (I) wherein R1 and R2 are independently hydrogen or C1-6 alkyl; Z is a group of sub-formula (a), (b), (c), (d) or (e): (a) Image (b) - 2 - (c) Image (d) wherein xa to xd are selected from hydrogen, halogen and hydroxy; R3 is hydrogen and R4 is hydrogen or C1-6 alkyl, or R3 and R4 together are a bond; R5 to R10 are independently selected from hydrogen or C1-6 alkyl; and R6 together with R4 may be C2-7 polymethylene when R3 is hydrogen, or R9 and R10 may together be C2-7 polymethylene; having 5-HT3 receptor antagonist activity, processes for their preparation and their use as pharmaceuticals.

593777

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazole derivatives having 5-ht3 receptor antagonist activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole derivatives having 5-ht3 receptor antagonist activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives having 5-ht3 receptor antagonist activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1307547

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.